TY - JOUR
T1 - The Transcribed-Ultra Conserved Regions
T2 - Novel non-coding RNA players in neuroblastoma progression
AU - Mudgapalli, Nithya
AU - Shaw, Brianna P.
AU - Chava, Srinivas
AU - Challagundla, Kishore B.
N1 - Publisher Copyright:
© 2019 by the authors.
PY - 2019
Y1 - 2019
N2 - The Transcribed-Ultra Conserved Regions (T-UCRs) are a class of novel non-coding RNAs that arise from the dark matter of the genome. T-UCRs are highly conserved between mouse, rat, and human genomes, which might indicate a definitive role for these elements in health and disease. The growing body of evidence suggests that T-UCRs contribute to oncogenic pathways. Neuroblastoma is a type of childhood cancer that is challenging to treat. The role of non-coding RNAs in the pathogenesis of neuroblastoma, in particular for cancer development, progression, and therapy resistance, has been documented. Exosmic non-coding RNAs are also involved in shaping the biology of the tumor microenvironment in neuroblastoma. In recent years, the involvement of T-UCRs in a wide variety of pathways in neuroblastoma has been discovered. Here, we present an overview of the involvement of T-UCRs in various cellular pathways, such as DNA damage response, proliferation, chemotherapy response, MYCN (v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)) amplification, gene copy number, and immune response, as well as correlate it to patient survival in neuroblastoma.
AB - The Transcribed-Ultra Conserved Regions (T-UCRs) are a class of novel non-coding RNAs that arise from the dark matter of the genome. T-UCRs are highly conserved between mouse, rat, and human genomes, which might indicate a definitive role for these elements in health and disease. The growing body of evidence suggests that T-UCRs contribute to oncogenic pathways. Neuroblastoma is a type of childhood cancer that is challenging to treat. The role of non-coding RNAs in the pathogenesis of neuroblastoma, in particular for cancer development, progression, and therapy resistance, has been documented. Exosmic non-coding RNAs are also involved in shaping the biology of the tumor microenvironment in neuroblastoma. In recent years, the involvement of T-UCRs in a wide variety of pathways in neuroblastoma has been discovered. Here, we present an overview of the involvement of T-UCRs in various cellular pathways, such as DNA damage response, proliferation, chemotherapy response, MYCN (v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)) amplification, gene copy number, and immune response, as well as correlate it to patient survival in neuroblastoma.
KW - Biomarkers
KW - Exosomes
KW - MYCN
KW - Metastasis
KW - MicroRNAs
KW - Neuroblastoma
KW - Oncogenes
KW - Therapy resistance
KW - Transcribed-ultra conserved regions
UR - http://www.scopus.com/inward/record.url?scp=85069899935&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85069899935&partnerID=8YFLogxK
U2 - 10.3390/NCRNA5020039
DO - 10.3390/NCRNA5020039
M3 - Review article
AN - SCOPUS:85069899935
SN - 2311-553X
VL - 5
JO - Non-coding RNA
JF - Non-coding RNA
IS - 2
M1 - 39
ER -